DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Su TH, Hu TH, Chen CY. et al.
Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients.
Liver Int 2016;
36: 1755-1764
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.